Prostate Cancer Terminated Phase 1 Trials for DB06448 (Lonafarnib)

Also known as: Prostatic Cancer / Prostatic neoplasms malignant / Carcinoma Prostate / Cancer Of Prostate / Malignant Neoplasm of Prostate / Prostate Cancers / Prostate carcinoma / Carcinoma of the prostate / Cancer, Prostate / Carcinoma of prostate / Prostatic carcinoma / Carcinoma prostatic / Ca prostate / Prostate cancer NOS

IndicationStatusPhase
DBCOND0062462 (Prostate Cancer)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00288444Interaction of Docetaxel and Lonafarnib in Patients With Advanced CancerTreatment